Tweet
Influenza Other Respir Viruses. 2018 Mar 5. doi: 10.1111/irv.12552. [Epub ahead of print]
Evaluating oseltamivir prescriptions in Centers for Medicare and Medicaid Services medical claims records as an indicator of seasonal influenza in the United States.
Dahlgren FS1, Shay DK1, Izurieta HS2, Forshee RA2, Wernecke M3, Chillarige Y3, Lu Y2, Kelman JA4, Reed C1.
Author information
Abstract
BACKGROUND:
Over 34 million residents of the United States aged 65 years old and older are also Medicare prescription drug beneficiaries. Medical claims records for this age group potentially provide a wealth of data for better understanding influenza epidemiology.
OBJECTIVE:
The purpose of this study was to evaluate data on oseltamivir dispensing extracted from medical claims records as an indicator of influenza activity in the United States for the 2010-11 through 2014-15 influenza seasons.
METHODS:
We used Centers for Medicare and Medicaid Services (CMS) medical claims data to evaluate the weekly number of therapeutic oseltamivir prescriptions dispensed following a rapid influenza diagnostic test among beneficiaries 65 years old and older as an indicator of influenza timing and intensity. We compared the temporal changes in this indicator to changes in the proportion of influenza-like illnesses among outpatient visits in the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) by administrative regions defined by the U.S. Department of Health and Human Services. Using the moving epidemic method, we determined intensity thresholds and categorized the severity of seasons for both CMS and ILINet data.
RESULTS:
CMS oseltamivir data and ILINet data were strongly correlated by administrative region (median Spearman's ρ = 0.78, interquartile range = 0.73-0.80). CMS oseltamivir data and ILINet data substantially agreed (Cohen's weighted κ = 0.62) as to the seasonal severity across administrative regions.
CONCLUSIONS:
Our results support the use of oseltamivir dispensing in medical claims data as an indicator of US influenza activity. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
Antivirals; Influenza; Medicare; Surveillance; Validity
PMID: 29505168 DOI: 10.1111/irv.12552
Evaluating oseltamivir prescriptions in Centers for Medicare and Medicaid Services medical claims records as an indicator of seasonal influenza in the United States.
Dahlgren FS1, Shay DK1, Izurieta HS2, Forshee RA2, Wernecke M3, Chillarige Y3, Lu Y2, Kelman JA4, Reed C1.
Author information
Abstract
BACKGROUND:
Over 34 million residents of the United States aged 65 years old and older are also Medicare prescription drug beneficiaries. Medical claims records for this age group potentially provide a wealth of data for better understanding influenza epidemiology.
OBJECTIVE:
The purpose of this study was to evaluate data on oseltamivir dispensing extracted from medical claims records as an indicator of influenza activity in the United States for the 2010-11 through 2014-15 influenza seasons.
METHODS:
We used Centers for Medicare and Medicaid Services (CMS) medical claims data to evaluate the weekly number of therapeutic oseltamivir prescriptions dispensed following a rapid influenza diagnostic test among beneficiaries 65 years old and older as an indicator of influenza timing and intensity. We compared the temporal changes in this indicator to changes in the proportion of influenza-like illnesses among outpatient visits in the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) by administrative regions defined by the U.S. Department of Health and Human Services. Using the moving epidemic method, we determined intensity thresholds and categorized the severity of seasons for both CMS and ILINet data.
RESULTS:
CMS oseltamivir data and ILINet data were strongly correlated by administrative region (median Spearman's ρ = 0.78, interquartile range = 0.73-0.80). CMS oseltamivir data and ILINet data substantially agreed (Cohen's weighted κ = 0.62) as to the seasonal severity across administrative regions.
CONCLUSIONS:
Our results support the use of oseltamivir dispensing in medical claims data as an indicator of US influenza activity. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
Antivirals; Influenza; Medicare; Surveillance; Validity
PMID: 29505168 DOI: 10.1111/irv.12552